Research from the University of South Australia shows that fentanyl is a safe option for mothers and babies, providing women with more pain relief choices during labour.
Medical professionals can now access a TGA-approved device to treat patients with chronic back pain, which affects 3.24 million Australians.
National Drug Research Institute has released the first national update on the cost of opioids in 13 years — it's not a pretty picture.
The wafer has been designed to provide rapid and more predictable absorption of cannabis, improved bioavailability and the potential for faster therapeutic action.
An AIHW report explores the latest national data on the proportion of people with chronic pain, as well as its impact, treatment and management.
How do we best respond to the pain experienced by some of the most frail and vulnerable people in our communities?
The move to prescription-only codeine in Australia has seen a 50% reduction in the monthly rate of codeine-related poisoning calls and halved codeine sales.
A new Australian prevalence study of hidradenitis suppurativa finds a high number of Australians have the devastating skin condition.
Estrogen and other sex hormones may be responsible for the higher prevalence of migraine in women.
A low dose of antidepressants has been shown to help treat back pain in those for whom narcotics are the remaining option.
Over 90% of Australians support the legalisation of medical use cannabis but only a handful of our 38,000 GPs are able to prescribe medicinal cannabis.
Taiwan Stanch has developed an environmentally friendly, re-usable hot/cold pack made from thermal clay.
Health practitioners are being asked to help raise awareness of chronic wounds, especially with at-risk ageing patients.
Does alcohol contribute to PMS, or does PMS drive women to alcohol? Researchers have found the surprising answer.
A man suffered unusual consequences when participating in a hot chilli pepper eating competition.